The 2 linked references in paper S. Chikina Yu., С. Чикина Ю. (2016) “Применение комбинации вилантерол / умеклидиния бромид в качестве базисной терапии у пациентов с хронической обструктивной болезнью легких // Vilanterol / umeclidinium bromide combination as a basic therapy for chronic obstructive pulmonary disease” / spz:neicon:pulmonology:y:2016:i:1:p:79-84

  1. Svedsater H., Jacques L., Goldfrad C., Bleecker E.R. Ease of use of the Ellipta dry powder inhaler: data from three randomized controlled trials in patients with asthma. Primary Care Respir. Med. 2014; 24: 14019. doi: 10.1038/npjpcrm. 2014.19
  2. Svedsater H., Dale P., Garrill K. et al. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.BMC Pulm. Med.2013; 13: 72. doi: 10.1186/1471-2466-13-72.